Ceregene is developing gene therapies for a variety of central nervous system disorders, including Alzheimer's disease, Parkinson's disease, and Lou Gehrig's disease. The company has signed two licensing agreements to develop its gene therapies with Genentech and the Salk Institute for Biological Studies.